John Canan

Insider Reports History

Entity
Individual
Location
C/O Rev Group, Inc., 111 East Kilbourn Avenue, Suite 2600, Milwaukee, WI
Signature
/s/ Stephen W. Boettinger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Canan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REV Group, Inc. Director Common Stock 59.7K $1.08M $18.17 Dec 8, 2023 Direct
REV Group, Inc. Director Restricted Stock Unit 63.3K Dec 5, 2024 Direct
Acasti Pharma Inc. Director Stock Options (Right to Buy) 45K Sep 28, 2022 Direct

Insider Reports Filed by John Canan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
REVG REV Group, Inc. Dec 5, 2024 1 $0 4 Dec 9, 2024 Director
REVG REV Group, Inc. Dec 8, 2023 1 $0 4 Dec 12, 2023 Director
REVG REV Group, Inc. Dec 8, 2022 1 $0 4 Dec 12, 2022 Director
ACST Acasti Pharma Inc. Sep 28, 2022 1 $0 4 Sep 30, 2022 Director
REVG REV Group, Inc. Dec 9, 2021 1 $0 4 Dec 13, 2021 Director
ACST Acasti Pharma Inc. Nov 12, 2021 1 $0 4 Nov 16, 2021 Director